On January 22, Zybio Inc. (hereinafter referred to as "Zybio") and Acchrom Technologies Co., Ltd. (hereinafter referred to as "Acchrom Tech") held a signing ceremony for the strategic cooperation agreement at Zybio’s headquarters in Chongqing, officially embarking on a deep collaboration in the fields of liquid chromatography and mass spectrometry.

Mr. Guo Yongli, General Manager of Zybio Inc., Mr. Denny Yang, General Manager of the Global Mass Spectrometry Division, Mr. Wang Lichun, Chairman of Acchrom Tech, and Mr. Yu Xiaoran, Chief Operating Officer, along with other related personnel, attended the ceremony to witness this significant moment.

Mr. Denny Yang, General Manager of Zybio’s Global Mass Spectrometry Division, and Mr. Wang Lichun, Chairman of Acchrom Tech, signed the strategic cooperation agreement as representatives of both parties, marking the official commencement of collaboration between Zybio Inc. and Acchrom Tech.

In his opening speech, Mr. Guo Yongli, General Manager of Zybio Inc., stated:

"Zybio Inc. has consistently maintained an open and collaborative approach and actively engaged in deep strategic cooperation with outstanding enterprises in the industry. This strategic partnership with Acchrom Tech stems from our shared philosophy and goals—committed to advancing the localization of liquid chromatography and mass spectrometry technologies. We firmly believe that through close collaboration, we can efficiently integrate resources and leverage complementary strengths to provide users with superior products and services. Together, we aim to achieve mutual growth and pioneer a new chapter in the localization of liquid chromatography and mass spectrometry technologies."

Mr. Denny Yang, General Manager of Zybio’s Global Mass Spectrometry Division, remarked during the discussions:

"Since the establishment, the Global Mass Spectrometry Division has been committed to becoming a value creator within the mass spectrometry ecosystem. We are oriented toward the global market, focusing on various types of mass spectrometry, including MALDI-TOF MS, nucleic acid mass spectrometry, triple quadrupole mass spectrometry, and TOF MS for teaching, covering fields such as clinical diagnostics, life sciences, pharmaceutical R&D, and environmental monitoring. By partnering with Acchrom Tech, we are confident in achieving breakthroughs in technology development and market expansion, driving localized LC-MS products to the global stage."

Mr. Wang Lichun, Chairman of Acchrom Tech, expressed:

"Acchrom Tech has always focused on innovation and breakthroughs in providing comprehensive solutions for liquid chromatography. This collaboration with Zybio Inc. presents new opportunities and challenges. We look forward to working closely with Zybio Inc. to explore innovative business models and development paths, injecting fresh momentum into the localization of liquid chromatography and mass spectrometry technologies in China and making significant contributions to the field."

We firmly believe that the partnership between Zybio Inc. and Acchrom Tech will yield fruitful results. Looking ahead, both sides will strengthen collaboration, leverage complementary strengths, and jointly explore new development opportunities, injecting robust momentum into China’s liquid chromatography and mass spectrometry sector. At the same time, we will continue to uphold the philosophy of openness and collaboration, anticipating opportunities to join hands with more outstanding enterprises to create a brighter future for the industry together!

About Acchrom Tech

Founded in 2015, Acchrom Tech (Beijing) Technology Co., Ltd. is a high-tech enterprise specializing in the R&D, production, sales, and technical services of chromatography separation products. It has received national certifications such as the "specialized, refined, special and new "little giant" enterprise" and the "National High-Tech Enterprise." The company has independently developed a domestic chromatography information management system with complete proprietary intellectual property rights and offers its own branded high-performance liquid chromatography instruments, ultra-high-performance liquid chromatography instruments, LC-MS systems, and consumables. These products are widely used in pharmaceuticals, food, environmental protection, disease control, clinical testing, inspection and quarantine, petrochemicals, and scientific research.

Zybio’s Global Mass Spectrometry Division

Established in 2008, Zybio Inc. is a national high-tech enterprise integrating the R&D, production, sales, and technical services of in vitro diagnostic reagents and instruments. The Zybio’s "Mass Spectrometry Family" centers around various types of mass spectrometry, MALDI-TOF MS, nucleic acid mass spectrometry, triple quadrupole mass spectrometry, and TOF MS for teaching, covering fields such as clinical diagnostics, life sciences, pharmaceutical R&D, and environmental monitoring. In 2025, Zybio’s Microbial&Mass Spectrometry Product Line was upgraded to operate under a BU, integrating R&D, production, sales, and service. The division adheres to a customer-centric approach, enhancing insights into user needs, strengthening specialized services, and precisely adapting to multi-product application scenarios in clinical diagnostics, life sciences, and analytical instruments, aiming to become a creator of value in the mass spectrometry ecosystem.